Pairwise Plants
Pairwise is a health-focused food and agriculture company leveraging CRISPR and gene editing techniques to transform plants and their production systems. The company has introduced the first CRISPR food to the North American market and collaborates with Bayer to advance agricultural research and development.
Services
Pairwise harnesses CRISPR and gene editing technologies to innovate in the food and agriculture sectors. Their Fulcrum™ platform accelerates plant-based innovations, providing proprietary tools like REDRAW™ and SHARC™ for precision gene editing. Pairwise offers expertise in creating specialized plant varieties, such as pitless cherries and seedless blackberries, targeting commercial partnerships and public health initiatives.
Products
Pairwise's product portfolio encompasses several innovative food items made through gene editing. Their consumer brand, Conscious™ Foods, includes the first CRISPR food product introduced to the North American market – mustard greens with enhanced nutritional value and better flavor. Other notable products in their pipeline are seedless, thornless, and higher-yielding berries, alongside edited leafy greens aimed at commercialization.
Strategic Alliances
Pairwise has established a strategic alliance with Bayer to advance gene-editing applications in agriculture. Through this partnership, Pairwise has delivered 27 novel traits to Bayer and is collaborating to develop climate-friendly short corn. This collaboration underscores Pairwise's commitment to agriculture research and innovation.
Funding and Recognition
In a successful series B funding round in February 2021, Pairwise raised $90 million, bringing their total fundraising to $115 million. Pairwise has been recognized as one of America's Top GreenTech Companies 2024 by TIME magazine, affirming their influence and accomplishments in green technology and sustainable agriculture.
Facilities and Infrastructure
Pairwise operates over 120,000 square feet of laboratory, greenhouse, and office spaces located across North Carolina and California. These facilities support their extensive research and development efforts, enabling the company to conduct precise gene-editing experiments and field trials across multiple crops.